Global Registry of Hemoglobinopathies

Global Registry of Hemoglobinopathies
Name	Global Registry of Hemoglobinopathies
Type	International medical registry
Founded	2010s
Headquarters	Geneva
Region served	Worldwide
Purpose	Surveillance, research, and care coordination for hemoglobinopathies
Leader title	Director

Contents

Global Registry of Hemoglobinopathies The Global Registry of Hemoglobinopathies is an international clinical and epidemiological initiative that aggregates patient-level data on inherited red blood cell disorders. Modeled after multinational efforts such as the World Health Organization, European Medicines Agency, Centers for Disease Control and Prevention, the registry seeks to harmonize surveillance across networks including the International Society of Hematology, World Federation of Hemophilia, and national programs like the National Institutes of Health, NHS England, and the Indian Council of Medical Research.

Introduction

Launched in collaboration with institutions such as the World Health Organization, World Bank, Bill & Melinda Gates Foundation, the registry builds on precedents set by registries like the Surveillance, Epidemiology, and End Results Program, European Cystic Fibrosis Society Patient Registry, and the Global Burden of Disease Study. It connects clinical centers affiliated with universities such as Harvard University, University of Oxford, University of Cambridge, Karolinska Institutet, and University of São Paulo, while interfacing with health ministries in countries including United States, United Kingdom, India, Nigeria, and Brazil.

The registry's primary aims align with priorities articulated by organizations like the United Nations, World Health Organization, and the Global Fund. It catalogs genotypes and phenotypes for disorders such as sickle cell disease, beta thalassemia, and rarer hemoglobin variants, enabling comparative studies across cohorts at centers such as Mayo Clinic, Johns Hopkins University, Aga Khan University, and Karolinska University Hospital. Scope includes longitudinal outcomes, treatment exposures referencing therapies approved by the European Medicines Agency and U.S. Food and Drug Administration, and public health metrics used by agencies like the Centers for Disease Control and Prevention and the European Centre for Disease Prevention and Control.

Governance draws on models used by entities including the Global Alliance for Vaccines and Immunization, Coalition for Epidemic Preparedness Innovations, and the International Committee of the Red Cross. A steering committee composed of representatives from the World Health Organization, regional bodies such as the Pan American Health Organization, academic centers like Imperial College London, patient organizations including Thalassaemia International Federation, and funders such as the Wellcome Trust oversees policy. Operational management often involves partnerships with research networks like the European Hematology Association and data platforms deployed by contractors experienced with United Nations procurement.

Data architecture adheres to standards promulgated by the International Organization for Standardization and interoperates with coding systems such as International Classification of Diseases and terminologies maintained by the National Library of Medicine and the World Health Organization. Clinical data fields mirror case report forms used in trials at institutions like Fred Hutchinson Cancer Center and St Jude Children's Research Hospital and align with laboratory standards from organizations like the Clinical and Laboratory Standards Institute. Genetic nomenclature is harmonized with conventions from the Human Genome Organisation and databases such as the European Bioinformatics Institute, while data exchange uses frameworks similar to those of the Global Alliance for Genomics and Health.

Ethical oversight is coordinated with institutional review boards patterned after models from Harvard School of Public Health, Johns Hopkins Bloomberg School of Public Health, and national ethics committees in jurisdictions like France, Germany, Kenya, and South Africa. Consent processes reference guidelines issued by the World Health Organization and the Council of Europe and must comply with laws such as those enacted in the European Union and statutes enforced by agencies including the U.S. Department of Health and Human Services. Data sharing agreements follow precedents from collaborations involving the International Committee of the Red Cross, Doctors Without Borders, and large-scale projects like the Human Genome Project.

The registry supports epidemiological modeling used by teams at the Institute for Health Metrics and Evaluation and policy recommendations mirroring those from the World Health Organization and United Nations Children's Fund. It informs clinical guidelines developed by the American Society of Hematology, European Hematology Association, and national societies such as the Indian Society of Hematology and Blood Transfusion. Research outputs influence translational programs at centers like Dana-Farber Cancer Institute, UCSF Medical Center, and vaccine and therapeutic development by entities including Novartis, Gilead Sciences, and biotechnology spinouts incubated by Massachusetts Institute of Technology.

Persistent challenges echo those faced by multinational projects like the Global Polio Eradication Initiative and the Global Fund: uneven infrastructure in regions represented by Nigeria, Democratic Republic of the Congo, Pakistan, and Bangladesh, variable regulatory environments exemplified by differences between the European Union and the United States, and funding sustainability beyond grants from bodies such as the Bill & Melinda Gates Foundation and the Wellcome Trust. Future directions include deeper integration with genomic resources at the European Bioinformatics Institute and National Center for Biotechnology Information, deployment of analytics informed by collaborators like Google DeepMind and IBM Watson Health, and expanded partnerships with patient organizations including Thalassaemia International Federation and Sickle Cell Disease Association of America.

Category:Medical registries Category:Hematology Category:International health organizations